Recently, Dr. Cassie Kline joined Children’s Hospital of Philadelphia as director of neuro-oncology clinical research. With over $2.5 million raised by the Kortney Rose Foundation for pediatric brain cancer research, Kline now has the backing from this foundation as she develops strategies and associated clinical trials programs targeting new treatments for children with brain tumors. The hope is that the combination of the foundation, CHOP and Dr. Kline will drive hope for future therapies to help children with this deadly form of cancer.
Dr. Kline brings a research focus centering on clinical trials for pediatric brain tumors. Presently leading four clinical trials as study chair and co-chair, she will continue these pursuits at CHOP, reports the Kortney Rose Foundation press release.
Kortney Rose Foundation
The Kortney Rose foundation is named after Kortney Rose, a child who died at the age of 9 due to an inoperable brain tumor back in 2006. Foundation founder Kristen Gillette reports the foundation is ecstatic to have Dr. Kline on board, noting, “We look forward to working together to accomplish our mutual goal of eradicating pediatric brain tumors in children.”
Cassie Kline, MD, Director Neuro-Oncology Clinical Research, Assistant Professor
Dr. Kline received her MD from University of California, San Diego, and first did her residency at CHOP then followed with a fellowship in pediatric hematology-oncology at the University of California, San Francisco. While at UCSF, she was recognized for her dedication and commitment to the quest to cure pediatric brain cancer with a number of awards and grants.